Johnson & Johnson: Need boost Dose in the fall

Some infectious disease specialists and other experts in the United States are considering the need for a booster dose with an mRNA vaccine (Pfizer / BioNTech or Moderna) for those who have had the Johnson & Johnson monosodium vaccine as the most contagious and possibly most dangerous Delta (“Indian”) of the coronavirus.

This variant is expected to dominate in Europe by the end of August, according to the European Center for Disease Prevention and Control (ECDC), but also in the US, according to the corresponding CDC.

Exit mobile version